|
From: Barry Scherr, Provost
To: Members of the President's Administrative Forum
I write to inform you that Dean Stephen Spielberg has decided to step down
this month from his position as head of the Dartmouth Medical School where he
has served for the past four and a half years. Dr. Spielberg has determined
that he would like to devote his time toward advancing therapeutic treatments
for children, as well as improving ascertainment and prevention of adverse drug
reactions nationally and internationally. These efforts continue a
long-standing research passion of his, which is reflected both in his 2006
presidency of the American Society for Clinical Pharmacology and Therapeutics
as well as his service as chair of the Scientific Advisory Board, NICHD
Pediatric Pharmacology Research Unit Network. Dr. Spielberg is internationally
recognized for his research and in 2007 he received an Award in Excellence in
Clinical Pharmacology from the PhRMA Foundation.
Dr. Spielberg will also continue his efforts to advance programs that seek
to improve the delivery of health care in several countries abroad. In
particular, the DMS involvement with the Global Health Initiative, a joint
program with the Dickey Center, came about during his deanship and has involved
both educational and research initiatives through its links with Muhimbili
University in Dar es Salaam.
While at DMS Dean Spielberg has devoted particular attention to the quality
of medical school education. Under his energetic leadership, the new PhD
program in Experimental and Molecular Medicine was established, and the school
developed and implemented DMEDS, a nationally recognized on-line system to
track educational goals for students against established clinical competencies.
He established new affiliations for the clinical education programs, and forged
a major alliance with the California Pacific Medical Center.
During his deanship Dean Spielberg emphasized the need for translational
science that brings advances from the laboratory to the patient. He served as
principal investigator for a Clinical and Translational Science planning grant,
and initiated planning for the C. Everett Koop Medical Science complex at DHMC
to house research groups with a focus on translational science. Dr. Spielberg
also strengthened relations with faculty at the Thayer School of Engineering
and at the Veterans Administration Hospital in White River Junction. I know
that you will join President James Wright and me in thanking Dr. Spielberg for
his service and enthusiastic work on behalf of the Medical School. He leaves
the school well positioned to take advantage of the opportunities ahead.
William Green, Chair of Microbiology and Immunology, has agreed to assume
the position of Dean, and I am grateful to him for his willingness to take on
this significant assignment. Bill has asked that his appointment as Dean be a
non-renewable term appointment to allow him to return to the Chairmanship of
the Department of Microbiology and Immunology and his research in due course. A
distinguished scientist who has been at Dartmouth Medical School since 1983,
Bill Green received his Bachelor of Science degree from the University of
Michigan and his Ph.D. from Case Western University. His post-doctoral research
was carried out first at Johns Hopkins, and then at the Fred Hutchinson Cancer
Research Center (FHCRC) and the University of Washington (UW) in Seattle. Here
at Dartmouth, from 1992 until 2002 he served as Director of the Immunology
Program. In recent years his laboratory has been primarily exploring immune
responses to retroviral diseases, including leukemia and immunodeficiency. Bill
will appoint a Senior Associate Dean for Clinical Affairs to help with the
issues associated with the clinical faculty and Dartmouth-Hitchcock. We hope to
announce that appointment in the very near future.
The President and I have also asked Adam Keller to serve as the Vice
President for Health Affairs. In this role Adam will use his broad knowledge of
the school to help with fundraising and public relations, and he will serve as
an advisor for Bill Green. Adam will continue to serve as the Executive Vice
President for the College; thus he will spend only a portion of his time at DMS
and will not have operating responsibilities. All elements of the Medical
School will report to Bill Green as Dean, and he in turn will report directly
to me.
|
